These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Safety profile of treatment in diabetic peripheral neuropathic pain.
    Author: Robinson-Papp J, Simpson DM.
    Journal: Pain Med; 2007 Sep; 8 Suppl 2():S43-9. PubMed ID: 17714115.
    Abstract:
    New treatment options for diabetic peripheral neuropathic pain (DPNP) have recently been developed, including two Food and Drug Administration (FDA) approved agents, duloxetine and pregabalin. As clinicians face a broader spectrum of efficacious treatments, side-effect profiles play an increasingly important role in the development of a pain management regimen. In this article we review the safety profile of agents commonly used in the treatment of DPNP.
    [Abstract] [Full Text] [Related] [New Search]